黃晨祐醫師詳細介紹

學歷

國立台灣大學臨床醫學研究所博士班進修中

國立台灣大學醫學系醫學士

經歷

日本小倉記念病院循環器內科臨床研究員

日本札幌心臟中心循環器內科臨床研究員

衛生福利部桃園醫院心臟內科主治醫師

衛生福利部金門醫院心臟內科主治醫師

台大醫院心臟內科臨床研究員

台大醫院內科部住院醫師、總住院醫師

中華民國心臟學會心臟專科訓練指導醫師

中華民國重症醫學專科醫師

中華民國心臟血管介入專科醫師

中華民國心臟學會心臟內科專科醫師

中華民國內科專科醫師

論文及學術著作

Huang CY, Lee JK, Wu HP, Chung WJ, Hsueh SK, Hsu PC, Chen CC, Huang CH, Huang HL. Outcomes After Paclitaxel Coated Device Use in Patients with Peripheral Artery Disease: A Nationwide Population Based Study. Eur J Vasc Endovasc Surg. 2025 Feb 8:S1078-5884(25)00120-0

Huang CY, Lee JK. Effects of SGLT2 Inhibitors with and without Metformin in High-Risk, Treatment-Naïve Patients with Diabetes. J Clin Med. 2024 Feb 28;13(5):1387.

Chen ZW, Chung YW, Cheng JF, Huang CY, Chen SY, Lin LY, Lai HC, Wu CK. Right Ventricular-Vascular Uncoupling Predicts Pulmonary Hypertension in Clinically Diagnosed Heart Failure With Preserved Ejection Fraction. J Am Heart Assoc. 2024 Jan 2;13(1):e030025.

Cheng JF, Huang PS, Chen ZW, Huang CY, Lan CW, Chen SY, Lin LY, Wu CK. Post-exercise left atrial conduit strain predicted hemodynamic change in heart failure with preserved ejection fraction. Eur Radiol. 2024 Mar;34(3):1825-1835.

Wu C-K, Cheng J-F, Huang C-Y, Chen Z-W, Chen S-Y, Lin L-Y. Iloprost and exercise haemodynamics in heart failure with preserved ejection fraction—the ILO-HOPE randomised controlled trial. Br J Clin Pharmacol. 2021; 87: 1165–1174.

Huang CY, Lee JK. Sodium-glucose co-transporter-2 inhibitors and major adverse limb events: A trial-level meta-analysis including 51 713 individuals. Diabetes Obes Metab. 2020 Dec;22(12):2348-2355.